Literature DB >> 4395460

Pharmacological aspects of oxprenolol.

H Brunner, P R Hedwall, R Maier, M Meier.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 4395460

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  9 in total

1.  Smoking and catecholamine and c-AMP concentrations in the coronary circulation of man and the effect of oxprenolol.

Authors:  R H Robson; D C Fluck
Journal:  Eur J Clin Pharmacol       Date:  1977-10-14       Impact factor: 2.953

2.  Pharmacodynamic studies in man of the beta-adrenoceptor antagonist DL 071 IT.

Authors:  M Radice; R Amanzio; D Criscuolo
Journal:  Eur J Clin Pharmacol       Date:  1979-09       Impact factor: 2.953

3.  Antihypertensive therapy with adrenergic beta-receptor blockers and vasodilators.

Authors:  W Aenishänslin; J Pestalozzi-Kerpel; U C Dubach; P R Imhof; M Turri
Journal:  Eur J Clin Pharmacol       Date:  1972-06       Impact factor: 2.953

Review 4.  Pharmacodynamic properties of beta-adrenergic receptor blocking drugs in man.

Authors:  D G Gibson
Journal:  Drugs       Date:  1974       Impact factor: 9.546

5.  Beta-adrenoceptor blocking agents and responses to adrenaline and 5-hydroxytryptamine in rat isolated stomach and uterus.

Authors:  Y Schechter; M Weinstock
Journal:  Br J Pharmacol       Date:  1974-10       Impact factor: 8.739

6.  Influence of the sympathomimetic activity of oxprenolol on haemodynamics in the anaesthetized dog.

Authors:  J Stepanek; H Brunner
Journal:  Basic Res Cardiol       Date:  1975 Sep-Oct       Impact factor: 17.165

7.  Interaction between oxprenolol and indomethacin on blood pressure in essential hypertensive patients.

Authors:  A Salvetti; F Arzilli; R Pedrinelli; P Beggi; M Motolese
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

8.  Evaluation of oxprenolol slow release and osmotic release by exercise testing and ambulatory electrocardiographic monitoring in patients with chronic stable angina pectoris.

Authors:  M J Bowles; N S Khurmi; M J O'Hara; E B Raftery
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

9.  Hypotensive effect of oxprenolol in mild to moderate hypertension: a multicentre controlled study.

Authors:  M Motolese; G Muiesan; A Colombi
Journal:  Eur J Clin Pharmacol       Date:  1975       Impact factor: 2.953

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.